Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 8;64(1):28-37.
doi: 10.1016/j.jacc.2014.04.031.

Contractile dysfunction of left ventricular cardiomyocytes in patients with pulmonary arterial hypertension

Emmy Manders  1 , Harm-Jan Bogaard  2 , M Louis Handoko  3 , Marielle C van de Veerdonk  2 , Anne Keogh  4 , Nico Westerhof  1 , Ger J M Stienen  5 , Cristobal G Dos Remedios  6 , Marc Humbert  7 , Peter Dorfmüller  8 , Elie Fadel  9 , Christophe Guignabert  10 , Jolanda van der Velden  11 , Anton Vonk-Noordegraaf  2 , Frances S de Man  12 , Coen A C Ottenheijm  13
Affiliations
Free article

Contractile dysfunction of left ventricular cardiomyocytes in patients with pulmonary arterial hypertension

Emmy Manders et al. J Am Coll Cardiol. .
Free article

Abstract

Background: After lung transplantation, increased left ventricular (LV) filling can lead to LV failure, increasing the risk of post-operative complications and mortality. LV dysfunction in pulmonary arterial hypertension (PAH) is characterized by a reduced LV ejection fraction and impaired diastolic function.

Objectives: The pathophysiology of LV dysfunction in PAH is incompletely understood. This study sought to assess the contribution of atrophy and contractility of cardiomyocytes to LV dysfunction in PAH patients.

Methods: LV function was assessed by cardiac magnetic resonance imaging. In addition, LV biopsies were obtained in 9 PAH patients and 10 donors. The cross-sectional area (CSA) and force-generating capacity of isolated single cardiomyocytes was investigated.

Results: Magnetic resonance imaging analysis revealed a significant reduction in LV ejection fraction in PAH patients, indicating a reduction in LV contractility. The CSA of LV cardiomyocytes of PAH patients was significantly reduced (~30%), indicating LV cardiomyocyte atrophy. The maximal force-generating capacity, normalized to cardiomyocyte CSA, was significantly reduced (~25%). Also, a reduction in the number of available myosin-based cross-bridges was found to cause the contractile weakness of cardiomyocytes. This finding was supported by protein analyses, which showed an ~30% reduction in the myosin/actin ratio in cardiomyocytes from PAH patients. Finally, the phosphorylation level of sarcomeric proteins was reduced in PAH patients, which was accompanied by increased calcium sensitivity of force generation.

Conclusions: The contractile function and the CSA of LV cardiomyocytes is substantially reduced in PAH patients. We propose that these changes contribute to the reduced in vivo contractility of the LV in PAH patients.

Keywords: contractile protein phosphorylation; left ventricular dysfunction; myocyte physiology; pulmonary arterial hypertension.

PubMed Disclaimer

Comment in

LinkOut - more resources